2027 Future Talent Program – Companion Animal Sales – Intern
Merck
Summary
The Future Talent Program features internships that last up to 12 weeks and will include one or more projects. These opportunities in our Animal Health division can provide you with great development and a chance to see if we are the right company for your long-term career goals.
Job description
The Companion Animal Summer Intern will be a field-based position. Location assignment is to be determined. The intern will serve as an ambassador for some of our leading parasiticide products and new technologies in the companion animal market. This position will be a field-based sales role working closely with our sales and sales management teams. The intern will provide added value to our Company's customers in companion animal veterinary clinics. The intern will interact with customers to gain firsthand sales experience.
The job scope and primary focus for this position is to actively support the sales strategy across the region and territory via coordination and execution of sales support activities including: Face to Face calls, literature orders, and other administrative tasks to drive sales in the region.
As a sales intern in our Animal Health Division, you will be required to rent a car. Candidates must be 20 years of age or older at the start of the internship to meet the necessary criteria to obtain a rental car agreement through our rental car provider.
Requirements
- Enrolled in any bachelor's degree program
- Completed at least 2 years of college coursework by May 2027
- Available May 24 – August 6, 2027
- Able to travel up to 50% and reside in the agreed upon city during summer 2027
- Excellent interpersonal/communication and presentation skills
- Computer skills including Word, Excel, PowerPoint and ability to use an iPad
- Must be 20 years of age or older at the start of the internship
- Organized, able to manage time, adapt to a changing environment, and work independently
Company overview
Merck & Co., Inc., known as Merck in the United States and Canada and MSD (Merck Sharp & Dohme) internationally, is a premier American multinational pharmaceutical company headquartered in Rahway, New Jersey. Founded in 1891 as the U.S. subsidiary of the German Merck Group, the company became independent following World War I and has since grown into one of the world's largest biomedical companies, ranking fourth globally by revenue. Merck operates across three core business segments: pharmaceuticals, vaccines, and animal health products. The company is renowned for its groundbreaking research and development, having brought numerous life-saving medicines to market including Keytruda (pembrolizumab), a leading immunotherapy for cancer treatment that generated $29.5 billion in 2024 revenue, and Gardasil, a revolutionary HPV vaccine. With approximately 75,000 employees worldwide, Merck maintains a robust pipeline of innovative therapies focused on oncology, vaccines, hospital acute care, cardiology, neuroscience, virology, immunology, and diabetes. The company invests heavily in R&D, spending $17.9 billion in 2024 alone, demonstrating its commitment to advancing scientific discovery. Merck's legacy spans over 130 years of bringing hope to humanity through important medicines and vaccines, operating with a purpose to use leading-edge science to save and improve lives globally while fostering an inclusive workforce and responsible business practices.